Power, John M., M. Mathew Oh, and John F. Disterhoft. Metrifonate decreases sI AHP in CA1 pyramidal neurons in vitro. J Neurophysiol 85: 319 -322, 2001. Metrifonate, a cholinesterase inhibitor, has been shown to enhance learning in aging rabbits and rats, and to alleviate the cognitive deficits observed in Alzheimer's disease patients. We have previously determined that bath application of metrifonate reduces the spike frequency adaptation and postburst afterhyperpolarization (AHP) in rabbit CA1 pyramidal neurons in vitro using sharp electrode current-clamp recording. The postburst AHP and accommodation observed in current clamp are the result of four slow outward potassium currents (sI AHP , I AHP , I M , and I C ) and the hyperpolarization activated mixed cation current, I h . We recorded from visually identified CA1 hippocampal pyramidal neurons in vitro using whole cell voltage-clamp technique to better isolate and characterize which component currents of the AHP are affected by metrifonate. We observed an age-related enhancement of the slow component of the AHP tail current (sI AHP ), but not of the fast decaying component of the AHP tail current (I AHP , I M , and I C ). Bath perfusion of metrifonate reduced sI AHP at concentrations that cause a reduction of the AHP and accommodation in current-clamp recordings, with no apparent reduction of I AHP , I M , and I C . The functional consequences of metrifonate administration are apparently mediated solely through modulation of the sI AHP .
I N T R O D U C T I O N
There is extensive evidence that acetylcholine (ACh) is an important neuromodulatory transmitter affecting hippocampaldependent learning and memory (Hagan and Morris 1988; Kaneko and Thompson 1997) . In addition, Alzheimer's disease (AD) and aging-related cognitive impairments have been correlated with a loss of cholinergic function Kasa et al. 1997; Muir 1997) . Consequently, enhancement of ACh effectiveness with procholinergic drugs, especially cholinesterase inhibitors (ChEI), has been a major thrust of AD treatment. Metrifonate, which is transformed nonenzymatically to 0,0-dimethyl 2,2-dichlorovinyl phosphate producing long-lasting inhibition of both acetylcholinesterase and butyrylcholinesterase (Nordgren et al. 1978) , has been shown to improve cognitive performance in AD patients (Cummings et al. 1998; Morris et al. 1998; Pettigrew et al. 1998 ) and, in our hands, to enhance hippocampal-dependent learning in aging rabbits (Kronforst-Collins et al. 1997) .
ACh modulates conductances in hippocampal neurons that mediate spike frequency adaptation (accommodation) and the postburst afterhyperpolarization (AHP) (Halliwell 1990; Lancaster and Adams 1986; Madison et al. 1987) . The cholinergic reduction of the AHP and accommodation is of particular interest since the AHP and accommodation are reduced in CA1 and CA3 hippocampal pyramidal neurons after hippocampally dependent trace eyeblink conditioning (Moyer et al. 1996 (Moyer et al. , 2000 Thompson et al. 1996b ). Accommodation and AHP are enhanced in CA1 neurons from animals at ages that show learning deficits (Landfield and Pitler 1984; Moyer et al. 1992 Moyer et al. , 2000 . Metrifonate reduces the AHP and accommodation in CA1 neurons in young and aging rabbits due to the muscarinic action of increased ambient ACh levels .
The postburst AHP (medium and slow AHP) and accommodation are regulated by at least four classes of outward potassium currents (I C , I M , sI AHP , and I AHP ), in addition the AHP is influenced by the mixed cation current, I h (Maccaferri et al. 1993; Stocker et al. 1999; Storm 1990) . Of these currents, I M and sI AHP are reduced by ACh in CA1 hippocampal neurons with ACh being 10-fold more potent at reducing sI AHP than I M in young rats (Madison et al. 1987 ). Recently we have shown an age-associated enhancement of the sI AHP and have hypothesized that enhancement of sI AHP is integrally involved in age-related learning deficits ). The following experiments were undertaken to determine whether metrifonate reduces the postburst AHP and accommodation by reducing the sI AHP .
M E T H O D S
Hippocampal slices (300 m) were prepared from young (2-3 mo) and aging (Ͼ31 mo) female New Zealand White rabbits using procedures identical to those previously published . Animal use procedures were approved by Northwestern University's Animal Care and Use Committee according to the standards of the US Department of Agriculture. Whole cell patch-clamp recordings were made from the soma of visually identified CA1 pyramidal neurons (Dodt and Zieglgansberger 1990) perfused with 31°C artificial cerebral spinal fluid (ACSF, composition, in mM: 124 NaCl, 3 KCl, 1.3 MgSO 4 , 1.24 NaH 2 PO 4 , 2.4 CaCl 2 , 26 NaHCO 3 , and 10 D-glucose). Patch electrodes (2-4 M⍀) were filled with (in mM) 2 K-ATP, 10 HEPES, 140 KMeSO 4 , and 10 KCl; pH 7.25, 280 Ϯ 10 mOsm. The use of MeSO 4 Ϫ in place of Cl Ϫ reduces the rundown of the slow AHP current over time (Zhang et al. 1994) .
Recordings were sampled at 5-10 kHz and filtered at 2 kHz using an Axopatch 1C amplifier (Axon Instruments, Foster City, CA) and controlled by custom software. Only neurons with an action potential amplitude Ͼ90 mV, membrane resistance Ͼ60 M⍀, and a stable series resistance Ͻ0.15 M⍀ were considered healthy and used in the data set. The AHP was evoked by a 100-ms voltage step to 0 mV from a holding potential of Ϫ55 mV. The Ϫ55-mV holding potential should eliminate the influence of I h , which activates at more hyperpolarized potentials. The medium (I AHP , I M , and I C ) and slow (sI AHP ) AHP components were separated using a curve peeling technique (Lancaster and Adams 1986; Womble and Moises 1993) (Fig. 1) . The sI AHP amplitude was also determined 1 s after pulse offset, after medium AHP currents are no longer active (Sah 1996; Stocker et al. 1999) .
Voltage-clamp measurements were taken immediately before and 20 min after application of metrifonate (young 50 M; aging 100 M). These concentrations of metrifonate were found to reduce the AHP and accommodation in sharp electrode current-clamp recordings comparably between young and aging neurons without inducing a bursting behavior . Sodium and potassium channel blockers were omitted to achieve the same cholinergic activity levels present in our previous current-clamp study . In some neurons, current-clamp measures of the AHP were also taken. In current clamp, the postburst AHP was evoked from a Ϫ68-mV holding potential using a 100-ms depolarizing current step that elicited four action potentials.
Age-related differences were analyzed with ANOVA. Drug-related effects were analyzed using paired t-tests. The correlation between current-clamp and voltage-clamp measures was tested using Fisher's r to z test.
Metrifonate was a gift from Bayer (West Haven, CT). KMeSO 4 was purchased from ICN (Aurora, OH). All other drugs were purchased from Sigma (St. Louis, MO).
R E S U L T S

Age effects
The AHP measures and passive membrane properties are given in Table 1 . The current-clamp AHP tended to be enhanced in neurons from aging animals [F(18, 1) ϭ 4.09, P ϭ 0.0583] as had been previously observed (Moyer et al. 1992; . In voltage-clamp mode, a 55-mV, 100-ms voltage step from a holding potential of Ϫ55 mV evoked a biphasic outward tail current in most neurons that slowly decayed back to baseline (Fig. 1 ). This tail current was separated into a fast (I fast ) and a slow (I slow ) decaying component representing the medium (I AHP , I M , and I C ) and slow (sI AHP ) AHP. The extrapolated amplitude of I slow [F(18, 1) ϭ 6.56, P ϭ 0.0196] and the tail current measured 1 s after pulse offset (1s_AHP) [F(20, 1) ϭ 15.85, P ϭ 0.0007] showed age related enhancements. There was no age-associated change in I fast .
FIG. 1. Age-associated changes in the afterhyperpolarization (AHP) tail current. A typical biphasic outward tail current (I tail ) decaying back to baseline is shown in A. A single exponential was fitted to the late portion (400 -3,000 ms) of the AHP and extrapolated to pulse offset (I slow ). I slow was subtracted from the total tail, and a 2nd exponential curve was fitted to the residual current and I fast (inset). Peeling was successful in 13 of 16 young and 4 of 5 aging neurons. An age-associated enhancement was observed in the slow component (B), but not the fast component (C). (9) n.s. Ϫ78.9 Ϯ 3.2 (5) Ϫ72.6 Ϯ 2.1 (5) 6.4 Ϯ 2.4 (5) n.s.
Values are means Ϯ SE. Numbers in parentheses indicate number of neurons for each measure. The number of neurons used in the young baseline group includes neurons that were used as saline controls. The effects of metrifonate, shown as the mean difference before and in the presence of metrifonate, were evaluated using a paired t-test P values with n Ϫ 1 degrees of freedom. Note that peeling of the fast and slow tail currents was not possible in all instances (see Fig. 1 legend) . AHP, afterhyperpolarization; n.s., not significant. 
Metrifonate effects
Bath application of metrifonate caused a reduction of the postburst AHP (Table 1) . Metrifonate also reduced the sI AHP , measured as either I slow or 1 s after pulse offset, in neurons from both young and aging animals ( Table 1, Fig. 2 ). Metrifonate did not produce a significant reduction in I fast , nor did the effect of metrifonate on the fast component differ from that of saline controls.
D I S C U S S I O N
An age-associated enhancement of the slow (sI AHP ), but not the fast (I AHP , I C , and I M ), component of the AHP tail current was observed. Furthermore metrifonate decreased the slow tail component (sI AHP ) in CA1 neurons from both young and aging animals at doses that reduce postburst AHP and accommodation in sharp-electrode current-clamp recordings ). We did not observe a metrifonate-induced reduction in the fast component of the AHP tail current. ACh is more potent at reducing sI AHP than I M (Madison et al. 1987) . However, since we were unable to adequately peel the fast component of the AHP in every instance and the relative contribution of I M to the fast tail component was not determined, it is unclear whether metrifonate reduced I M as well as sI AHP .
Metrifonate was shown to be less potent at reducing the postburst AHP and accommodation of CA1 neurons of aging than young rabbits in our previous current-clamp studies that evaluated dose-response relationships in the two age groups . Metrifonate doses that produced a comparable reduction of the postburst AHP in young and aging neurons , caused a similar reduction of the sI AHP . Thus metrifonate appears to modulate neuronal excitability similarly in neurons from young and aging subjects. It is likely that the age-related potency differences are due to reduced levels of endogenous ACh release observed in aging subjects in vivo (Vannucchi et al. 1997) .
In summary, metrifonate reduces the AHP, in particular, the sI AHP . The AHP and accommodation are reduced after hippocampally dependent trace eyeblink conditioning (Moyer et al. 1996; Thompson et al. 1996b) . The sI AHP is enhanced in CA1 neurons from aging rabbits , a group that is learning-impaired (Thompson et al. 1996a ). Metrifonate facilitates learning in aging rabbits (Kronforst-Collins et al. 1997) . Similar results were obtained with the M1 muscarinic agonist CI-1017, and the L-type calcium channel blocker, nimodipine. Both of these compounds reduce the AHP and accommodation in vitro and facilitate acquisition of trace eyeblink conditioning when administered to aging rabbits (Deyo et al. 1989; Moyer et al. 1992; Weiss et al. 2000) . As a whole, these data support our hypothesis that the sI AHP is integrally involved in age-related learning impairments and suggest that the functional consequences of metrifonate administration are mediated through modulation of the sI AHP . More generally, they suggest that the ability of a drug to reduce the sI AHP may be a good predictor of that compound's ability to facilitate learning, especially in aging subjects. The inset bar graph shows the percent reduction (mean Ϯ SE) of the sI AHP measured 1 s after pulse offset after metrifonate application in young (young 50 M; n ϭ 12) and aging neurons (aging 100 M; n ϭ 5). Also shown in the bar graph is the sI AHP reduction observed when normal saline (n ϭ 4) was perfused over the same 20-min time period. The saline perfusate served as a control for normal rundown. The 30% reduction of the sI AHP in metrifonate is greater than the 4% reduction observed in saline controls [ANOVA: 1s_AHP F(15, 1) ϭ 9.616, P ϭ 0.0085; I slow F(12, 1) ϭ 8.060, P ϭ 0.0149].
